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Abstract
A modified BioBrick™ assembly method was developed with higher fidelity than current protocols. The method
utilizes a PCR reaction with a standard primer set to amplify the inserted part. Background colonies are reduced by
a combination of dephosphorylation and digestion with DpnI restriction endonuclease to reduce vector and insert
background respectively. The molar ratio of the insert to vector in the ligation was also optimized, with the
accuracy of the transformed construct approaching 100%.
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Background
The methods used for controlled modification of genetic
material have experienced several major improvements
since the initial development of recombinant DNA techni-
ques in the early 1970s [1-4]. While there have been many
efforts to simplify and standardize the genetic assembly
process [5-7], one format that has gained widespread
acceptance is the BioBrick™[8]. BioBrick assembly is com-
monly applied within a synthetic biology conceptual fra-
mework that abstracts and classifies basic functional units
of genetic material (promoters, ribosome binding sites,
protein coding sequences like reporters, terminators, etc.)
as “parts” that can be assembled into “devices” that create
new functionality, and higher level “systems” to accom-
plish complex tasks [9]. While the BioBrick standard has
been revised several times [10-12], the basic format has
remained the same. Each “BioBrick part” is contained on a
plasmid and is flanked by four unique restriction sites,
(two 5’ and two 3’) with the inner restriction sites that can
be cut by two endonucleases yielding compatible ends.
Using this format, individual parts may be selectively
digested and then ligated together to form new composite
parts or devices while preserving the format, connecting
the individual parts by a benign mixed restriction site
known as a “scar” (Figure 1). The chief utility of this tech-
nology is that all parts using the same format are inter-
changeable and composite parts can be recombined in the
same way as individual parts [8]. This has allowed entire
catalogs of compatible biological parts to be developed
[9,13]. The major limitation of this format is that compo-
site parts must be assembled piece by piece. To make
this system useful and affordable, easy and reliable stan-
dard methods of performing these assemblies have been
developed [14].
The original method used to perform “bio-bricking” is
called the standard assembly method. In using this
method, one part is designated the insert and is digested
out of its plasmid using enzymes EcoRI and SpeI or XbaI
and PstI [8]. The other part remains in its plasmid, but
the plasmid is opened up using compatible enzymes:
EcoRI and XbaI or SpeI and PstI respectively (Figure 2).
Upon successful double ligation the inner XbaI and SpeI
sticky ends will form a benign scar and the two parts will
be adjacent to one another in the final circular construct.
This protocol requires the following steps: 1) extraction
of plasmids containing the two parts to be assembled; 2)
digestion of the plasmids to create compatible ends on
DNA fragments; 3) separation of the digested DNA by
agarose gel electrophoresis; 4) extraction of the selected
fragments from the gel; 5) ligation of the fragments
together; and 6) transformation of the ligated plasmid
product into cells. This process has many advantages: the
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parts can all be on plasmids with the same antibiotic
resistance; thermostable enzymes (e.g. BglII and BamHI)
can be used; and only two successful ligations are neces-
sary to achieve a circularized plasmid. However, there is
a key disadvantage: the gel electrophoresis and extraction
are difficult to automate and result in poor yields of puri-
fied DNA, especially for smaller parts.
To address many of these problems, the three antibio-
tic (3A) assembly method was developed [15]. This
method successfully eliminates the necessity for gel elec-
trophoresis and the associated costs/problems/time and
enables the automated assembly of small parts. Using
this method the two plasmids containing the parts to be
assembled are extracted as before, but both parts (desig-
nated “prefix” and “suffix”) are digested out of their
respective plasmids and then inserted into a third plas-
mid in a three way ligation. This third plasmid is called
the “construction plasmid” and has a different antibiotic
resistance than the part plasmids (Figure 3). Various
means are employed to eliminate background transfor-
mation of the construction plasmid including the inser-
tion of a specific “cell death” gene [16-18] and the use
of PCR-linearized plasmid backbone [14]. While this 3A
Assembly greatly simplifies the assembly of biological
parts, it has some disadvantages as well. The three-way
ligations are less efficient and produce comparatively
fewer circularized products and fewer transformants. It
is also possible for these backbones to be ligated to the
construction plasmid in place of the desired part
because the digested prefix and suffix plasmid back-
bones are included in the ligation. Both of these pro-
blems lead to a loss of accuracy and the need to screen
and sequence a number of colonies.
We proposed and critically tested an alternate BioBrick
assembly method called Amplified Insert Assembly to
eliminate many of these problems. This method com-
bines the functional simplicity of the standard assembly
method with the ease and flexibility of 3A Assembly and
is compatible with any BioBrick standard in which the
restriction endonucleases are able to be heat inactivated.
It is based on the original standard assembly method in
that it uses a double ligation to insert one part, desig-
nated the “insert”, adjacent to another part that remains
in its plasmid, and thus is the designated “vector”. The
need for gel electrophoresis is eliminated because the
insert is amplified from its original plasmid using high-
fidelity PCR, and background transformation is elimi-
nated by simple enzymatic treatments. Very small parts
can also be assembled with ease because this PCR step
adds sufficient length to allow purification using a DNA
binding column. While these combined treatments elimi-
nate the need for gel electrophoresis and enable the
assembly of small parts, they also substantially decrease
the required starting quantity of DNA, generally making
use of the BioBrick repository more affordable and
versatile.
Several aspects of the amplified insert (AI) assembly
protocol will be familiar to those using standard cloning
techniques, as they are very similar to the processes
involved in typical cloning of DNA [19]. This new
assembly protocol is differentiated by 1) the use of com-
mon flanking primers which preserve, during amplifica-
tion, the existing restriction sites flanking the BioBrick
part, 2) these primers also add sufficient length of DNA
(~300 bp) to the amplified part to allow even very small
parts (e.g. RBSs) to be purified easily using a DNA
Figure 1 Assembly of Parts Using the BioBrick Standard Format. The promoter and the protein coding sequence, initially existing as parts
on separate plasmids, are digested and ligated to form a composite part on one plasmid. Because XbaI (TCTAGA) and SpeI (ACTAGT) form
compatible ends (CTAG), the two individual parts are connected by a mixed restriction site (ACTAGA) that is not recognized by any restriction
endonuclease and is called the “scar”. The individual parts may exist on plasmids with different resistances and the final composite parts may or
may not be on a plasmid with the same resistance as its constituent parts.
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binding column, 3) clean-up of the amplified insert by
DpnI digestion, and 4) the elimination of background
vector by the dephosphorylation of the vector DNA.
Results
The protocol for utilizing the AI assembly method is
simple and fast. First, the plasmid DNA for both parts is
purified from an overnight culture. The insert DNA is
then amplified from its plasmid using 25 cycles of high-
fidelity PCR. This amplification uses standard primers
that anneal to all BioBrick plasmids and eliminate the
need to order custom oligos for each assembly, as
required by other PCR based assembly methods [20-22].
While this PCR is running, the vector plasmid is
digested with either EcoRI and XbaI or SpeI and PstI.
After two hours of digestion, the vector is also treated
with Antarctic Phosphatase to remove the terminal
phosphates in the cut vector and prevent self-ligation.
When the PCR product is finished it is purified using a
DNA binding column and then digested for one hour
with either EcoRI and SpeI or XbaI and PstI to comple-
ment the vector. DpnI is also added to this digest as a
Figure 2 Standard Assembly. This figure illustrates a typical standard assembly. The plasmid containing the promoter is digested with SpeI and
PstI, and the plasmid containing the coding sequence is digested with XbaI and PstI. Both of these digests are separated using agarose gel
electrophoresis and the relevant parts are recovered from the gel. The gel extracts are then ligated together and the circular product is
transformed into cells. Because of the necessity for gel electrophoresis, performing this same assembly using the small-sized promoter as the
insert instead of the protein coding sequence would be extremely difficult.
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third restriction endonuclease. Once all digests are
heated to inactivate the endonucleases (80°C for 20
min), they are ligated using T4 Ligase at a molar ratio
of 4:1 (insert:vector), transformed into competent cells,
and plated onto media of appropriate resistance. This
method is illustrated in Figure 4.
The high accuracy of this assembly is enabled by the
use of DpnI restriction endonuclease to eliminate insert
background and Antarctic Phosphatase to eliminate vec-
tor background. This additional processing is an enzy-
matic substitute for the mechanical separation of gel
electrophoresis, and can be performed concurrently to
the restriction digest without requiring any additional
time. DpnI restriction endonuclease is a frequent blunt
cutter (recognition site GATC) but only cuts sites with
a methylated adenine residue [23]. Many cloning strains
of E. coli are positive for Dam methyltransferase which
specifically methylates this GATC site [24], making it
susceptible to DpnI cleavage. Because the synthetic
DNA created during PCR amplification is not methy-
lated, the DpnI only cuts the template DNA. Thus the
PCR followed by digestion with DpnI provides an enzy-
matic amplification and clean-up of the BioBrick insert.
Similarly, the use of a phosphatase prohibits the cut
Figure 3 Three Antibiotic (3A) Assembly. Using this method of assembly, the promoter is digested with EcoRI and SpeI and the coding
sequence is digested with XbaI and PstI. A PCR linearized “construction plasmid” with a different antibiotic resistance than the others is also
digested with EcoRI and PstI and may or may not be treated with DpnI and phosphatase to remove some of the background plasmids. These
three digests are then ligated together and the circular product of that ligation is transformed into cells.
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vector DNA from re-ligating by removing the terminal
phosphate groups necessary to bond DNA bases. To
verify and quantify the accuracy and efficiency of AI
assembly, promoters and protein coding sequences of
various sizes were inserted to create functional BioBrick
expression cassettes for the lacZ a fragment [25] and
mRFP[26], allowing the constructs to be screened by
color. In addition to the traditional additive assembly
procedure, AI assembly was also used for coding
sequence replacement, which is commonly used for pro-
moters that are contained in testing devices (Figure 5).
The molar ratios of insert to vector were adjusted to
determine the optimum for this protocol, as this ratio
has been shown to have a substantial effect on ligation
Figure 4 Amplified insert Assembly. The insert part is amplified from its plasmid using high-fidelity PCR and the purified PCR product is
digested with XbaI, PstI, and DpnI. Meanwhile the vector part’s plasmid is digested with SpeI and PstI and phosphatased. The products of these
two digestions are then ligated and the circular product is transformed into cells. This assembly can easily be done in reverse manner using the
promoter as the insert and leaving the coding sequence in its vector, thus providing additional flexibility.
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Figure 5 Experimental Amplified Insert Assemblies. 1) The Ptet promoter is amplified from its plasmid and inserted 5’ of lacZ a with RBS.
The amplified fragment is 350 bp and the insert size is 50 bp. 2) The J23100 constitutive promoter is amplified from its testing device and
inserted 5’ of lacZ a. The amplified fragment is 1200 bp and the insert size is 40 bp. 3) The lacZ a is amplified from its plasmid and is inserted 3’
of the J23100 promoter while replacing the existing coding sequence in the testing device and restoring the standard BioBrick format. The
amplified fragment is 830 bp and the insert size is 530 bp. 4) The entire promoter testing device is amplified from its plasmid and inserted 3’ of
lacZ a creating a composite mRFP generator and testing device. The amplified fragment is 1200 bp and the insert size is 900 bp.
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success [27]. As a comparison, three antibiotic (3A)
assembly was also performed as instructed in the Bio-
Brick™ assembly kit (Ginkgo BioWorks, Boston MA,
USA). For all assemblies the insert parts were initially
contained on ampicillin resistant BioBrick plasmids, and
all composite parts were contained on chloramphenicol
resistant plasmids. This allowed the separate assessment
of insert background in AI assembly by plating the
transformation product on ampicillin plates. This back-
ground number allows us to quantify the additional
number of incorrect colonies if the vector and insert
plasmids both had the same resistance. This background
assessment was not done for 3A assembly, as this
method requires that the construction plasmid have a
different resistance than the prefix or suffix and there-
fore the insert background is theoretically insignificant
as it would not appear on plates of the correct
resistance.
The results of these tests are summarized in Table 1.
Non-colored chloramphenicol resistant colonies are
enumerated as “incorrect” and colonies that appear on
ampicillin plates are enumerated as “background”. The
3A assemblies were each transformed twice (column
purified/concentrated and unpurified) to ensure suffi-
cient colonies for enumeration, as the unpurified 3A
ligation produced only a few colonies. The unpurified
transformation data are given first. All AI assembly liga-
tions were transformed unpurified. For the AI assembly
tests, various combinations of placing the insert 5’ (liga-
tions #1 and #2) or 3’ (ligations #3 and #4) of the vector
part are represented. Sequences of the assembled parts
are available in [Additional File 1].
Conclusions
Based on these results shown in Table 1 it can be seen
that the amplified insert assembly method produces the
desired composite part with greater accuracy when com-
pared to 3A assembly. There is also a greater trend
toward success at the higher molar ratios, with the 4:1
(insert:vector) ratio giving greater accuracy in three out
of the four assemblies tested. Furthermore, it can be
seen that the amplified insert assembly is equally adept
at performing the standard additive assembly (ligations
#1 and #4) as well as coding sequence replacement (liga-
tions #2 and #3). These results also show a trend toward
decreased accuracy when the insert is placed behind the
vector part (ligations #3 and #4). This could be due to
the lower activity of PstI in the reaction buffer used
(75% compared to 100% for all other enzymes according
the NEB’s buffer chart). While this can be slightly
Table 1 Transformation Results
Amplified Insert Assembly
# Ligation Inputs Results
Insert Vector Ratio Color Correct Incorrect Background % Accuracy
Ptet lacZ a 1:1 Blue 819 6 1 99.6 ± 0.9%
1 Ptet lacZ a 2:1 Blue 868 13 1 98.4 ± 0.7%
Ptet lacZ a 4:1 Blue 793 0 1 99.9 ± 0.2%
PJ23100 lacZ a 1:1 Blue 778 3 3 99.2 ± 0.6%
2 PJ23100 lacZ a 2:1 Blue 1454 5 1 99.6 ± 0.8%
PJ23100 lacZ a 4:1 Blue 607 0 1 99.8 ± 0.3%
lacZ a PJ23100 1:1 Blue 391 12 6 95.6 ± 2.2%
3 lacZ a PJ23100 2:1 Blue 547 2 3 99.1 ± 0.7%
lacZ a PJ23100 4:1 Blue 465 5 1 98.7 ± 3.3%
mRFP Driver lacZ a 1:1 Red 676 34 5 94.6 ± 3.4%
4 mRFP Driver lacZ a 2:1 Red 1329 24 1 98.2 ± 0.9%
mRFP Driver lacZ a 4:1 Red 1761 22 6 98.4 ± 1.0%
Three-Antibiotic Assembly
# Ligation Inputs Results
Prefix Suffix Vector Color Correct Incorrect % Accuracy
5 PJ23100 lacZ a pSB1C3 Blue 8 1 89%
5* PJ23100 lacZ a pSB1C3 Blue 418 43 90.7 ± 0.6%
6 lacZ a mRFP Driver pSB1C3 Red 3 1 75%
6* lacZ a mRFP Driver pSB1C3 Red 174 29 85.7 ± 4.6%
The cumulative number of colonies after performing assemblies in triplicate on three separate days are shown. 3A ligations marked with an asterisk (*) were
purified and concentrated before transformation. The highest % accuracy is bolded for each ligation reaction.
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frustrating, it also illuminates the fact that the amplified
insert assembly method allows an added level of choice
in determining which enzymes to use. In contrast, with
3A assembly all enzymes must be used for every assem-
bly. While it should be noted that the extremely low
numbers of colonies given by the unpurified 3A ligation
is a substantial limitation of this method, this limitation
is readily eliminated by a quick purification step. Similar
assemblies were also performed using the standard
assembly method with gel electrophoresis. These assem-
blies had an accuracy of 94%, but only yielded an aver-
age of three colonies per plate, and none of the
assemblies involving small inserts yielded any colonies.
These results show that the amplified insert assembly
method preserves the functional simplicity (and therefore
accuracy) of the original standard assembly method while
possessing several positive characteristics of 3A assembly,
including the elimination of gel electrophoresis and the
ability to assemble small parts. While the PCR step can
sometimes add up to two hours to the total assembly
time, the total time from cultures to plating is usually
under six hours, and the hands-on time is only slightly
increased when compared to 3A assembly. Furthermore,
because this protocol allows the amplification of insert
from a small amount of DNA, plasmid preps of common
parts (e.g. promoters, terminators, and RBSs) can be kept
as a stock and used repeatedly as insert template. If the
PCR is performed in advance from a plasmid stock, the
total time required for AI assembly is four hours. A com-
parison of the various BioBricking methods can be found
in Table 2.
Because this procedure uses PCR to amplify the insert,
there is an inherent risk of causing mutations in the
part sequence. To mitigate this risk a few steps should
always be taken: 1) a high fidelity polymerase should
always be used; 2) the number of PCR cycles should be
kept at or below 30; and 3) the final construct should
always be sequenced to detect any mutations. It also
occasionally happens that PCR can unexpectedly fail for
a number of reasons, but because our reaction uses the
same polymerase and primers for each assembly, the use
of a standard 2× stock can drastically reduce the user
error involved in the amplification process. Despite
these risks we have yet to observe a mutated plasmid in
over 100 successful sequenced assemblies, and have
found this method to be a quick, effective, and reliable
way to perform all types of BioBrick assembly.
Methods
For all experiments E. coli strain DH5a was grown in
SOB liquid medium [28] supplemented with appropriate
antibiotic (100 μg/ml Ampicillin; 50 μg/ml Kanamycin;
35 μg/ml Chloramphenicol) or on 2% agar plates at 37°C
supplemented with X-gal (200 mg/L) and the appropriate
antibiotic. All parts and plasmids used in this experiment
were obtained from the Registry of Standard Biological
Parts http://partsregistry.org/Main_Page, and a list of the
parts and plasmids used is provided in Table 3. Plasmids
were extracted using the E.Z.N.A Plasmid Mini Kit
(Omega Bio-Tek, Norcross, GA, USA). DNA was quanti-
fied using a NanoDrop 2000 spectrophotometer (Thermo
Scientific, Wilmington, DE, USA).
Amplified insert assembly
PCR
Parts were amplified via PCR using the high fidelity
Vent® DNA Polymerase (New England BioLabs, Ips-
wich, MA, USA) and run according to the suppliers
protocol (2011) in 1× Thermopol Buffer (2 mM Mg2
+) for 25 cycles (25 sec@94°C, 25 sec@58°C, exten-
sion (1 min/kb)@72°C). Primers VF2 (tgccacct-
gacgtctaagaa) and VR (attaccgcctttgagtgagc) were
used that flank the restriction sites by approximately
125 bp and have a Tm of 60°C. PCR cleanups were
performed using the E.Z.N.A. Cycle-Pure Kit
(Omega Bio-Tek, Norcross, GA, USA).
Digestion
All digests were performed in 50 μl volumes con-
taining 1x NEBuffer 2 (New England BioLabs,
Table 2 Comparison of Alternative Assembly Methods
Standard Assembly Three Antibiotic Assembly Amplified Insert Assembly
Plasmid Extraction X X X
Restriction Digest X X X




Ligation X X X
Purification After Gel Before Transformation Before Digestion
Accuracy Depends on size: Gel extraction difficult for small inserts 89% 99%
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Ipswich, MA, USA) and either 0.5 pmol of purified
PCR product or 0.25 pmol of purified plasmid.
Twenty units of each enzyme were used for the
digests, except for SpeI and Antarctic Phosphatase
which were used in 10 unit and 5 unit quantities
respectively. Digests were performed according to
the following scheme:
To place the insert part in 5’ of the vector part. The
vector was digested with EcoRI and XbaI for two hours
(while the insert PCR was taking place) and then treated
with Antarctic Phosphatase (supplemented with the spe-
cified buffer) for one hour while the purified insert was
digested with DpnI, EcoRI, and SpeI;
To place the insert 3’of the vector part. The vector was
digested with SpeI and PstI for two hours (while the
insert PCR was taking place) and then treated with Ant-
arctic Phosphatase (supplemented with the specified
buffer) for one hour while the insert was digested with
DpnI, XbaI, and PstI.
All digests were heat inactivated for 20 min at 80°C.
All enzymes were purchased from New England Bio-
Labs (Ipswich, MA, USA).
Ligation
Ligations were performed in 20 μl volumes using T4
Ligase (New England BioLabs, Ipswich, MA, USA)
according to the manufacturers protocol (2011) for
sticky ends. A total of 6 μl of unpurified digests was
used for each ligation, with the molar ratios varied
from 1:1 to 4:1 (insert:vector).
Three-antibiotic (3A) assembly
vector construction
The backbone of the plasmid pSB1C3 was amplified
and linearized via PCR using Phusion® High-Fidelity
DNA Polymerase (New England BioLabs, Ipswich,
MA, USA). Phusion® was used here because it has
high processivity (4 kb/minute), a higher fidelity
than Vent®, and works well for large parts or, in this
case, a 2.5 kb plasmid backbone. However, because
of its high processivity Phusion® is not ideal for the
amplification of small parts, which is why Vent® was
used elsewhere. Primers which bind in the BioBrick
sites and have a Tm of 61°C were used for 35 cycles
according to the manufacturer’s (2011) specifica-
tions. Constructs were purified using the E.Z.N.A.
Cycle-Pure Kit and used immediately.
Digestion
0.25 pmol of DNA were used for all 50 μl digests.
The prefix parts were digested with EcoRI and SpeI
and the suffix parts were digested with XbaI and
PstI. The linear construct plasmid was digested with
EcoRI and PstI and also supplemented with DpnI
and Antarctic Phosphatase to eliminate background
as described above. During the phosphatase step,
vector digests were supplemented with 6 μl of Ant-
arctic Phosphatase buffer. All reactions were heat
inactivated for 20 min at 80°C after three hours of
digestion.
Ligation
2 μl of each digest (6 μl total) was added to the liga-
tion mix as described above. The ligations were
done in duplicate with one ligation being trans-
formed in its unpurified state, while the other liga-
tion was purified using an E.Z.N.A MicroElute
Cycle-Pure Kit (Omega Bio-Tek, Norcross, GA,
USA) and concentrated in a volume of 5 μl, which
was used in its entirety to transform cells.
Transformation and selection
5 μl of ligation product was added to 100 μl DH5a
competent cells (1 × 107 cfu/μg DNA) and transformed
using an Eppendorf 2510 electroporator (Hamburg, Ger-
many) at 15,000 V/cm. Transformed cells were diluted
into 900 μl prewarmed SOC medium [28] and let
recover for 30-60 min at 37°C. 100 μl of this recovery
solution was then plated in triplicate on chlorampheni-
col plates and singly on an ampicillin plate to assess
Table 3 Parts and Plasmids
Part# Description Size (bp) Use Plasmid Resistance
BBa_I732018 lacZ a with a strong ribosome binding site 534 Insert pSB1AK3 Ampicillin, Kanamycin
BBa_J23100 Strong constitutive promoter in mRFP testing device 35 + 890 Insert pBca1020 Ampicillin
BBa_R0040 TetR repressible promoter 54 Insert pSB1A2 Ampicillin
BBa_I732018 lacZ a with a strong ribosome binding site 534 Vector pSB1C3 Chloramphenicol
BBa_J23100 Strong constitutive promoter in mRFP testing device 35 + 890 Vector pSB1C3 Chloramphenicol
The plasmids used are described according to the parts registry number www.partsregistry.org and the size of the BioBrick part contained on the plasmid. Parts
given two sizes are promoters contained on promoter testing devices that have an mRFP coding sequence between the SpeI and PstI sites. The sizes are given
as the promoter and mRFP gene respectively.
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background insert plasmid (for AI assembly only). The
plates were developed for two days before color counts
were made. Strains containing only lacZa (without a
promoter), as well as the mRFP driver were also tested
to ensure that they did not produce a false positive for
the X-gal screen.
Additional material
Additional file 1: Gene Sequences. This file contains the gene
sequences of the parts used as well as the final constructs created by
assembly.
List of abbreviations used
RBS: ribosome binding site; ORF: open reading frame; mRFP: monomeric red
fluorescent protein; PCR: polymerase chain reaction; SOB super optimal
broth; bp: base pairs.
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